Elizabeth A. Cody
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth A. Cody has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Scott Jacob Ellis
Foot & Ankle Service, Hospital for Special Surgery, New York, NY, USA
24 shared publications Constantine A. Demetracopoulos
Orthopedic Foot and Ankle Surgery, Hospital for Special Surgery, New York, NY, USA
11 shared publications- Jensen K. Henry
Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
10 shared publications - Matthew S. Conti
Foot and Ankle Service, Hospital for Special Surgery, New York, NY, USA
8 shared publications James A. Nunley
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA
6 shared publicationsScott J. Ellis
Hospital for Special Surgery, New York, NY, USA
6 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 11 (2)
Late Bone Marrow Edema Associated With Use of a Bioresorbable Polymer Suture Anchor in Foot and Ankle Surgery
Background: Bioresorbable orthopaedic implants have proliferated in recent years, including suture anchors, soft tissue scaffolds, and screws. At our institution, we anecdotally noticed late inflammatory-type reactions in the bone surrounding a particular bioresorbable polymer suture anchor. This bioresorbable anchor (BRA) uses ultrasonic technology to liquefy its tip, allowing interdigitation with surrounding cancellous bone. The polymer is designed to resorb around 2-3 years. In this study, we aimed to characterize complications associated with its use. Methods: A retrospective review was conducted of foot and ankle procedures using the BRA between 2018 and 2023, using a prospectively collected foot and ankle registry. Of the 62 patients who received at least 1 of these implants, 42 (68%) were female. Chart review was used to identify postoperative complications, particularly pain with bone marrow edema (BME) surrounding the anchor(s), as detected on magnetic resonance imaging (MRI). Patients were classified according to their primary diagnoses and level of physical activity. Patients with and without BME were compared to each other. Results: Twenty (32%, 95% CI 22%-45%) patients developed an inflammatory response at a mean of 27 months postoperatively. Four patients (20%) developed BME less than 1 year postoperatively, whereas the remaining 16 patients (80%) developed BME more than 2 years postoperatively. BME occurred more often in females ( P = .047), and when used in the setting of trauma ( P = .039). Symptoms resolved with nonoperative treatment in all but 3 cases (15%). No revision surgeries were performed. Conclusion: Nearly one third of the patients developed symptomatic bone marrow edema localized to the bioresorbable anchor. Female sex and ankle fracture were variables significantly associated with development of BME. Not all symptoms resolved with nonoperative treatment. These findings suggest caution should be exercised when using bioresorbable anchors. Level of Evidence: Level IV, retrospective review.
- 1 April 2026
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 11 (2)
Open AccessLate Bone Marrow Edema Associated With Use of a Bioresorbable Polymer Suture Anchor in Foot and Ankle Surgery
Background: Bioresorbable orthopaedic implants have proliferated in recent years, including suture anchors, soft tissue scaffolds, and screws. At our institution, we anecdotally noticed late inflammatory-type reactions in the bone surrounding a particular bioresorbable polymer suture anchor. This bioresorbable anchor (BRA) uses ultrasonic technology to liquefy its tip, allowing interdigitation with surrounding cancellous bone. The polymer is designed to resorb around 2-3 years. In this study, we aimed to characterize complications associated with its use. Methods: A retrospective review was conducted of foot and ankle procedures using the BRA between 2018 and 2023, using a prospectively collected foot and ankle registry. Of the 62 patients who received at least 1 of these implants, 42 (68%) were female. Chart review was used to identify postoperative complications, particularly pain with bone marrow edema (BME) surrounding the anchor(s), as detected on magnetic resonance imaging (MRI). Patients were classified according to their primary diagnoses and level of physical activity. Patients with and without BME were compared to each other. Results: Twenty (32%, 95% CI 22%-45%) patients developed an inflammatory response at a mean of 27 months postoperatively. Four patients (20%) developed BME less than 1 year postoperatively, whereas the remaining 16 patients (80%) developed BME more than 2 years postoperatively. BME occurred more often in females ( P = .047), and when used in the setting of trauma ( P = .039). Symptoms resolved with nonoperative treatment in all but 3 cases (15%). No revision surgeries were performed. Conclusion: Nearly one third of the patients developed symptomatic bone marrow edema localized to the bioresorbable anchor. Female sex and ankle fracture were variables significantly associated with development of BME. Not all symptoms resolved with nonoperative treatment. These findings suggest caution should be exercised when using bioresorbable anchors. Level of Evidence: Level IV, retrospective review.
- 27 January 2026
- Published by SAGE Publications in Foot & Ankle International
- Vol. 47 (2) , 165-171
Periprosthetic Metabolic Activity After Total Ankle Arthroplasty: Cross-Sectional 18 F-NaF PET/CT Data From Asymptomatic Patients at 6-24 Months
Background: Radionuclide bone scintigraphy in combination with computed tomography (CT) is increasingly used as a diagnostic tool to evaluate the painful total ankle arthroplasty (TAA). However, uptake patterns following uncomplicated TAA have not been investigated. In this study, we aimed to establish normative data on periprosthetic metabolic activity following TAA. Methods: Thirty-two asymptomatic patients who underwent TAA with a modern fixed-bearing prosthesis for posttraumatic arthritis were included. Patients underwent 18 F-NaF positron emission tomography (PET) at 1 of 4 time intervals following TAA: 6, 12, 18, or 24 months, with 8 different patients enrolled at each time point. Standard uptake values (SUVs) were measured at the bone-implant interface in regions of interest (ROIs) defined on axial CT scan slices. Periprosthetic bone blood flow ( K 1 ) and bone turnover ( k i , flux) were quantified from dynamic 18F-NaF PET/CT. Results: Tracer uptake in the talus increased from 6 to 12 months postoperatively, subsequently declining from 12 to 24 months. Uptake in the tibia was similar at 6 and 12 months, and steadily decreased thereafter. SUVs, K 1 , and k i in both the tibia and talus decreased significantly between 12 and 24 months ( P -adj < .05). SUVs, K 1 , and k i in the talus exceeded those measures in the tibia at 12, 18, and 24 months postoperatively ( P -adj < .05). Conclusion: The present study demonstrates that in asymptomatic patients, periprosthetic tracer uptake peaks at 12 months and remains elevated up to 24 months following modern fixed-bearing TAA. In both the tibia and talus, uptake decreased between 12 and 24 months. Talar uptake was higher than tibial uptake at 12, 18, and 24 months. Our findings suggest that radionuclide bone scintigraphy should be cautiously interpreted especially when performed within 2 years of TAA.
- 27 January 2026
- Published by SAGE Publications in Foot & Ankle International
- Vol. 47 (2) , 165-171
Periprosthetic Metabolic Activity After Total Ankle Arthroplasty: Cross-Sectional 18 F-NaF PET/CT Data From Asymptomatic Patients at 6-24 Months
Background: Radionuclide bone scintigraphy in combination with computed tomography (CT) is increasingly used as a diagnostic tool to evaluate the painful total ankle arthroplasty (TAA). However, uptake patterns following uncomplicated TAA have not been investigated. In this study, we aimed to establish normative data on periprosthetic metabolic activity following TAA. Methods: Thirty-two asymptomatic patients who underwent TAA with a modern fixed-bearing prosthesis for posttraumatic arthritis were included. Patients underwent 18 F-NaF positron emission tomography (PET) at 1 of 4 time intervals following TAA: 6, 12, 18, or 24 months, with 8 different patients enrolled at each time point. Standard uptake values (SUVs) were measured at the bone-implant interface in regions of interest (ROIs) defined on axial CT scan slices. Periprosthetic bone blood flow ( K 1 ) and bone turnover ( k i , flux) were quantified from dynamic 18F-NaF PET/CT. Results: Tracer uptake in the talus increased from 6 to 12 months postoperatively, subsequently declining from 12 to 24 months. Uptake in the tibia was similar at 6 and 12 months, and steadily decreased thereafter. SUVs, K 1 , and k i in both the tibia and talus decreased significantly between 12 and 24 months ( P -adj < .05). SUVs, K 1 , and k i in the talus exceeded those measures in the tibia at 12, 18, and 24 months postoperatively ( P -adj < .05). Conclusion: The present study demonstrates that in asymptomatic patients, periprosthetic tracer uptake peaks at 12 months and remains elevated up to 24 months following modern fixed-bearing TAA. In both the tibia and talus, uptake decreased between 12 and 24 months. Talar uptake was higher than tibial uptake at 12, 18, and 24 months. Our findings suggest that radionuclide bone scintigraphy should be cautiously interpreted especially when performed within 2 years of TAA.
- 26 November 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 47 (1) , 62-71
Early Clinical, Radiographic, and Patient-Reported Outcomes of the Infinity With Adaptis Total Ankle System
Background: The Infinity with Adaptis Total Ankle System (Stryker, Mahwah, NJ) is a low-profile, fixed-bearing implant that became available for use in October 2019. The aim of this study was to describe the early clinical and radiographic outcomes of the Infinity with Adaptis implant at minimum 2-year follow-up. Methods: A retrospective review of 71 ankles that underwent primary total ankle arthroplasty (TAA) with Infinity with Adaptis implants between November 2019 and November 2021 at a single institution was completed. Chart review was performed to identify complications, reoperations, and revision procedures. Preoperative and postoperative radiographs were measured to assess tibiotalar alignment and identify periprosthetic lucencies, cysts, or subsidence. Patient-Reported Outcomes Measurement Information System (PROMIS) scores were collected preoperatively and at 1 and 2 years postoperatively to assess clinical outcomes. Results: At final follow-up (average 2.7 ± 0.6 years), 68 of the 71 ankles remained implanted (95.8%). Three ankles were revised within 1.5 years of the index procedure (1 for talar component loosening and 2 for infection). There were an additional 5 (7.0%) reoperations at an average of 16.0 (range: 1.1-37.1) months postoperatively. Patients demonstrated both clinically and statistically significant improvements in preoperative to 1-year postoperative PROMIS scores ( P < .0001). There was no statistically significant improvement in scores from 1 to 2 years postoperatively. There was improvement in radiographic alignment from the preoperative to postoperative radiographs ( P < .001), and tibial component lucency was observed in 20 of 71 without progressive global lucency during the study window. Conclusion: Patients who underwent total ankle arthroplasty with the Infinity with Adaptis Total Ankle Replacement demonstrated significant improvements in radiographic and clinical outcomes at a minimum of 2-year follow-up with 95.8% (68/71) implant retention and a tibial lucency rate of 28.2% in this cohort. These observational findings warrant mid- to long-term surveillance to determine the clinical significance of early lucencies and the durability of this design’s porous-surface osseointegration.
- 26 November 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 47 (1) , 62-71
Early Clinical, Radiographic, and Patient-Reported Outcomes of the Infinity With Adaptis Total Ankle System
Background: The Infinity with Adaptis Total Ankle System (Stryker, Mahwah, NJ) is a low-profile, fixed-bearing implant that became available for use in October 2019. The aim of this study was to describe the early clinical and radiographic outcomes of the Infinity with Adaptis implant at minimum 2-year follow-up. Methods: A retrospective review of 71 ankles that underwent primary total ankle arthroplasty (TAA) with Infinity with Adaptis implants between November 2019 and November 2021 at a single institution was completed. Chart review was performed to identify complications, reoperations, and revision procedures. Preoperative and postoperative radiographs were measured to assess tibiotalar alignment and identify periprosthetic lucencies, cysts, or subsidence. Patient-Reported Outcomes Measurement Information System (PROMIS) scores were collected preoperatively and at 1 and 2 years postoperatively to assess clinical outcomes. Results: At final follow-up (average 2.7 ± 0.6 years), 68 of the 71 ankles remained implanted (95.8%). Three ankles were revised within 1.5 years of the index procedure (1 for talar component loosening and 2 for infection). There were an additional 5 (7.0%) reoperations at an average of 16.0 (range: 1.1-37.1) months postoperatively. Patients demonstrated both clinically and statistically significant improvements in preoperative to 1-year postoperative PROMIS scores ( P < .0001). There was no statistically significant improvement in scores from 1 to 2 years postoperatively. There was improvement in radiographic alignment from the preoperative to postoperative radiographs ( P < .001), and tibial component lucency was observed in 20 of 71 without progressive global lucency during the study window. Conclusion: Patients who underwent total ankle arthroplasty with the Infinity with Adaptis Total Ankle Replacement demonstrated significant improvements in radiographic and clinical outcomes at a minimum of 2-year follow-up with 95.8% (68/71) implant retention and a tibial lucency rate of 28.2% in this cohort. These observational findings warrant mid- to long-term surveillance to determine the clinical significance of early lucencies and the durability of this design’s porous-surface osseointegration.
- 24 July 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (11) , 1207-1217
Patient-Specific Instrumentation Does Not Improve Alignment Compared to the Extramedullary Foot Holder for the INBONE II Total Ankle Arthroplasty
Background: Patient-specific instrumentation (PSI) was developed to improve accuracy and efficiency in implant placement for total ankle arthroplasty (TAA). This study represents the first to measure the accuracy of PSI regarding implant alignment and implant size in the INBONE II total ankle system (Stryker). A secondary goal was to compare radiographic and clinical outcomes between the PSI and that of a matched group of implants performed with standard instrumentation. Methods: This retrospective study of 92 patients (46 PSI and 46 non-PSI cases matched by age and sex) was performed at a single institution between 2006 and 2024, including TAA patients with INBONE II implants. Median age was 61 years (range 27-81). Median body mass index (BMI) was 29.6 (range 19.9-45.6). One surgeon performed 71% of PSI. A different surgeon performed 96% of non-PSI cases. PSI alignment (tibiotalar angle [TTA]), deformity correction (talar-tilt [TT]), radiation exposure, tourniquet, and operative time were compared to the standard jig method (non-PSI). Total fluoroscopy, tourniquet and procedure time, and preoperative and postoperative radiographs were analyzed. Results: PSI predicted the correct size in 67% (n = 31) of talus implants and 89% (n = 41) of tibial implants. Median absolute deviation in the mortise view was 1.3 (IQR 0.53-2.18) and 1.8 (IQR 1.35-3.5) in the lateral view. For both groups, postoperative median TTA deviation was less than 2 degrees and postoperative median TT was less than or equal to 1 degree. Median fluoroscopic time was 92.1 seconds for PSI and 104.3 seconds for non-PSI. PSI had a longer tourniquet (156.5 vs 134.5 minutes) and procedure time (188 vs 161 minutes) compared with non-PSI. Conclusion: In this study of stemmed TAA implants, surgeons achieved alignment generally consistent with PSI predictions. PSI adequately predicted implant size. For most cases, PSI achieved similar alignment and correction of deformity compared with standard instrumentation. PSI did not improve radiographic alignment compared with traditional instrumentation and was associated with longer operative times, possibly reflecting the primary surgeon’s early experience with the technique. Each surgeon should select PSI or the standard jig based on their experience and preference.
- 24 July 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (11) , 1207-1217
Patient-Specific Instrumentation Does Not Improve Alignment Compared to the Extramedullary Foot Holder for the INBONE II Total Ankle Arthroplasty
Background: Patient-specific instrumentation (PSI) was developed to improve accuracy and efficiency in implant placement for total ankle arthroplasty (TAA). This study represents the first to measure the accuracy of PSI regarding implant alignment and implant size in the INBONE II total ankle system (Stryker). A secondary goal was to compare radiographic and clinical outcomes between the PSI and that of a matched group of implants performed with standard instrumentation. Methods: This retrospective study of 92 patients (46 PSI and 46 non-PSI cases matched by age and sex) was performed at a single institution between 2006 and 2024, including TAA patients with INBONE II implants. Median age was 61 years (range 27-81). Median body mass index (BMI) was 29.6 (range 19.9-45.6). One surgeon performed 71% of PSI. A different surgeon performed 96% of non-PSI cases. PSI alignment (tibiotalar angle [TTA]), deformity correction (talar-tilt [TT]), radiation exposure, tourniquet, and operative time were compared to the standard jig method (non-PSI). Total fluoroscopy, tourniquet and procedure time, and preoperative and postoperative radiographs were analyzed. Results: PSI predicted the correct size in 67% (n = 31) of talus implants and 89% (n = 41) of tibial implants. Median absolute deviation in the mortise view was 1.3 (IQR 0.53-2.18) and 1.8 (IQR 1.35-3.5) in the lateral view. For both groups, postoperative median TTA deviation was less than 2 degrees and postoperative median TT was less than or equal to 1 degree. Median fluoroscopic time was 92.1 seconds for PSI and 104.3 seconds for non-PSI. PSI had a longer tourniquet (156.5 vs 134.5 minutes) and procedure time (188 vs 161 minutes) compared with non-PSI. Conclusion: In this study of stemmed TAA implants, surgeons achieved alignment generally consistent with PSI predictions. PSI adequately predicted implant size. For most cases, PSI achieved similar alignment and correction of deformity compared with standard instrumentation. PSI did not improve radiographic alignment compared with traditional instrumentation and was associated with longer operative times, possibly reflecting the primary surgeon’s early experience with the technique. Each surgeon should select PSI or the standard jig based on their experience and preference.
- 8 July 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (7) , 807
Response to “Letter Regarding: Incidence of Complications With Precontoured Allograft Wedges in Foot and Ankle Surgery”
- 8 July 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (7) , 807
Response to “Letter Regarding: Incidence of Complications With Precontoured Allograft Wedges in Foot and Ankle Surgery”
- 18 March 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (6) , 608-616
Early Periprosthetic Tibial Lucency Following Low-Profile Total Ankle Arthroplasty
Background: Most modern total ankle arthroplasty (TAA) implants have low-profile designs that minimize tibial resection and use small pegs or posts for fixation. A number of studies have identified concerning rates of lucencies around the tibial components of these implants. In this study, we evaluated a consecutive series of patients receiving an anterior approach low-profile TAA prosthesis to describe the incidence, characteristics, and progression of tibial component lucencies at short-term (minimum 1-year) follow-up. Methods: Patients who underwent primary TAA with a modern low-profile TAA tibial implant from 2014 through 2021 were identified from a prospectively collected TAA registry. Poorly defined lucency around the tibial component in all 4 tibial zones, as agreed on by 2 independent reviewers, was considered “global lucency.” Intraoperative, 1-year, and 2-year postoperative radiographs were assessed for periprosthetic lucencies. Patients with global lucency at 1 year were compared to the remaining patients. Results: 554 ankles with a mean 29 ± 19 months of follow-up met inclusion criteria. Twenty-one ankles (3.8%) were revised for tibial loosening. Thirty-six ankles (6.5%) had global tibial lucency at 1 year. Of these, 15 (42%) were eventually revised and the remaining 21 (58%) were doing well clinically at final follow-up. Following multivariable regression, postoperative coronal tibiotalar offset ≥2 degrees (adjusted odds ratio [OR] = 3.60, P = .017), use of the Vantage implant (adjusted OR = 2.84, P = .006), and male sex (adjusted OR = 2.71, P = .016) were predictors of global lucency at 1 year. Conclusion: At 1 year after anterior approach low-profile TAA, we found a 6.5% incidence of global lucency around the tibial component, suggestive of lack of osseous integration of the prosthesis. Fifty-eight percent of patients with global lucency did not require revision and were doing well clinically at early follow-up. Higher postoperative coronal tibiotalar offset, use of the Vantage implant, and male sex were all significantly associated with development of global lucency.
- 18 March 2025
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (6) , 608-616
Early Periprosthetic Tibial Lucency Following Low-Profile Total Ankle Arthroplasty
Background: Most modern total ankle arthroplasty (TAA) implants have low-profile designs that minimize tibial resection and use small pegs or posts for fixation. A number of studies have identified concerning rates of lucencies around the tibial components of these implants. In this study, we evaluated a consecutive series of patients receiving an anterior approach low-profile TAA prosthesis to describe the incidence, characteristics, and progression of tibial component lucencies at short-term (minimum 1-year) follow-up. Methods: Patients who underwent primary TAA with a modern low-profile TAA tibial implant from 2014 through 2021 were identified from a prospectively collected TAA registry. Poorly defined lucency around the tibial component in all 4 tibial zones, as agreed on by 2 independent reviewers, was considered “global lucency.” Intraoperative, 1-year, and 2-year postoperative radiographs were assessed for periprosthetic lucencies. Patients with global lucency at 1 year were compared to the remaining patients. Results: 554 ankles with a mean 29 ± 19 months of follow-up met inclusion criteria. Twenty-one ankles (3.8%) were revised for tibial loosening. Thirty-six ankles (6.5%) had global tibial lucency at 1 year. Of these, 15 (42%) were eventually revised and the remaining 21 (58%) were doing well clinically at final follow-up. Following multivariable regression, postoperative coronal tibiotalar offset ≥2 degrees (adjusted odds ratio [OR] = 3.60, P = .017), use of the Vantage implant (adjusted OR = 2.84, P = .006), and male sex (adjusted OR = 2.71, P = .016) were predictors of global lucency at 1 year. Conclusion: At 1 year after anterior approach low-profile TAA, we found a 6.5% incidence of global lucency around the tibial component, suggestive of lack of osseous integration of the prosthesis. Fifty-eight percent of patients with global lucency did not require revision and were doing well clinically at early follow-up. Higher postoperative coronal tibiotalar offset, use of the Vantage implant, and male sex were all significantly associated with development of global lucency.
- 19 November 2024
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (1) , 29-36
Incidence of Complications With Precontoured Allograft Wedges in Foot and Ankle Surgery
Background: Precontoured cancellous allograft wedges have gained popularity in foot and ankle procedures in recent years because of their ease of use and ability to decrease operative time. A high rate of resorption of such wedges was noted anecdotally by the senior authors, particularly in 2022. The purpose of this study was to identify the resorption and complication rates of precontoured allograft wedges over time. Methods: A retrospective review was performed of patients who had a precontoured allograft wedge from a single source implanted during foot and ankle surgery between 2017 and 2022 at a single institution. Patient demographics, indication for graft use, and fixation method were obtained from chart review, and differences between patients with and without nonunion were analyzed. Radiographic review was completed to identify patients with graft resorption and/or nonunion. Results: Of the 334 wedges implanted, 24 grafts (7.2%) resorbed and an additional 10 wedges (2.9%) developed a nonunion without resorption. Resorption was noted as early as 5.7 weeks postoperatively and as late as 36.6 weeks postoperatively. Older patient age, body mass index (BMI) >30, and the Lapidus graft type were significantly associated with greater risk of resorption or nonunion. Conclusion: We observed an overall radiographic complication rate of 10% with the use of precontoured cancellous wedges. Older age, BMI >30, and Lapidus wedge type were associated with increased risk of radiographic complication. Patients should be counseled on the risk of resorption and nonunion, and caution should be exercised when contemplating the use of precontoured allograft cancellous wedges in foot and ankle surgery.
- 19 November 2024
- Published by SAGE Publications in Foot & Ankle International
- Vol. 46 (1) , 29-36
Incidence of Complications With Precontoured Allograft Wedges in Foot and Ankle Surgery
Background: Precontoured cancellous allograft wedges have gained popularity in foot and ankle procedures in recent years because of their ease of use and ability to decrease operative time. A high rate of resorption of such wedges was noted anecdotally by the senior authors, particularly in 2022. The purpose of this study was to identify the resorption and complication rates of precontoured allograft wedges over time. Methods: A retrospective review was performed of patients who had a precontoured allograft wedge from a single source implanted during foot and ankle surgery between 2017 and 2022 at a single institution. Patient demographics, indication for graft use, and fixation method were obtained from chart review, and differences between patients with and without nonunion were analyzed. Radiographic review was completed to identify patients with graft resorption and/or nonunion. Results: Of the 334 wedges implanted, 24 grafts (7.2%) resorbed and an additional 10 wedges (2.9%) developed a nonunion without resorption. Resorption was noted as early as 5.7 weeks postoperatively and as late as 36.6 weeks postoperatively. Older patient age, body mass index (BMI) >30, and the Lapidus graft type were significantly associated with greater risk of resorption or nonunion. Conclusion: We observed an overall radiographic complication rate of 10% with the use of precontoured cancellous wedges. Older age, BMI >30, and Lapidus wedge type were associated with increased risk of radiographic complication. Patients should be counseled on the risk of resorption and nonunion, and caution should be exercised when contemplating the use of precontoured allograft cancellous wedges in foot and ankle surgery.
- 21 October 2024
- Published by SAGE Publications in HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery
- Vol. 22 (1) , 42-49
Radiographic and Clinical Outcomes of First Tarsometatarsal Joint Arthrodesis With a Biplanar Locking Plate System Versus the Modified Lapidus Technique With Crossed-Screw Fixation: A Retrospective Multicenter Comparison
Background : Hallux valgus (HV) is recognized as a triplanar deformity. A biplanar locking plate (BLP) system corrects this deformity through first tarsometatarsal joint (TMTJ) arthrodesis, with specialized reduction tools and cutting guides. Yet the optimal surgical technique and fixation construct for first TMTJ arthrodesis remains controversial. Purpose : We sought to compare the BLP system with a modified Lapidus (ML) technique with crossed-screw fixation in terms of radiographic outcomes, complications, and reoperations. Methods : In this retrospective multicenter study, we identified a series of consecutive patients who underwent first TMTJ arthrodesis for HV with either the ML procedure at institution A or the BLP system at institution B. Patients 18 years of age with a minimum of 6 months of postoperative radiographs were included. There were 130 patients, 65 in each group, including 121 women (93.8%) with a median age of 58 years and mean radiographic follow-up of 7.1 months. Data included preoperative and postoperative HV angle (HVA), intermetatarsal angle (IMA), and tibial sesamoid position (TSP), plus complications and reoperations. Statistical testing included Mann-Whitney U , Wilcoxon signed rank, Fisher exact, McNemar, and multivariable regression. Results : After adjusting for confounding variables, the BLP system was associated with significantly greater improvements in postoperative IMA and HVA but not TSP. There were no significant differences in rates of complications (ML: 18.4%; BLP: 9.2%) or reoperations (ML: 4.6%; BLP: 7.7%). Conclusion : This retrospective multicenter review found that the BLP system was associated with greater improvement in radiographic HV parameters compared with the ML procedure using crossed-screw fixation. Clinical significance is unclear as complication and reoperation rates were similar between groups. Further study in this regard is warranted.
- 21 October 2024
- Published by SAGE Publications in HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery
- Vol. 22 (1) , 42-49
Radiographic and Clinical Outcomes of First Tarsometatarsal Joint Arthrodesis With a Biplanar Locking Plate System Versus the Modified Lapidus Technique With Crossed-Screw Fixation: A Retrospective Multicenter Comparison
Background : Hallux valgus (HV) is recognized as a triplanar deformity. A biplanar locking plate (BLP) system corrects this deformity through first tarsometatarsal joint (TMTJ) arthrodesis, with specialized reduction tools and cutting guides. Yet the optimal surgical technique and fixation construct for first TMTJ arthrodesis remains controversial. Purpose : We sought to compare the BLP system with a modified Lapidus (ML) technique with crossed-screw fixation in terms of radiographic outcomes, complications, and reoperations. Methods : In this retrospective multicenter study, we identified a series of consecutive patients who underwent first TMTJ arthrodesis for HV with either the ML procedure at institution A or the BLP system at institution B. Patients 18 years of age with a minimum of 6 months of postoperative radiographs were included. There were 130 patients, 65 in each group, including 121 women (93.8%) with a median age of 58 years and mean radiographic follow-up of 7.1 months. Data included preoperative and postoperative HV angle (HVA), intermetatarsal angle (IMA), and tibial sesamoid position (TSP), plus complications and reoperations. Statistical testing included Mann-Whitney U , Wilcoxon signed rank, Fisher exact, McNemar, and multivariable regression. Results : After adjusting for confounding variables, the BLP system was associated with significantly greater improvements in postoperative IMA and HVA but not TSP. There were no significant differences in rates of complications (ML: 18.4%; BLP: 9.2%) or reoperations (ML: 4.6%; BLP: 7.7%). Conclusion : This retrospective multicenter review found that the BLP system was associated with greater improvement in radiographic HV parameters compared with the ML procedure using crossed-screw fixation. Clinical significance is unclear as complication and reoperation rates were similar between groups. Further study in this regard is warranted.
- 29 May 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (15) , 1404-1410
Defining the Patient Acceptable Symptom State (PASS) for PROMIS After Total Ankle Replacement
Background: Although patient-reported outcomes (PROs), such as the Patient-Reported Outcomes Measurement Information System (PROMIS), are a key element of evaluating success after total ankle replacement (TAR), many do not explicitly state a key factor of postoperative success: is the patient satisfied with their outcome after TAR? The patient acceptable symptom state (PASS) represents the symptom threshold beyond which patients consider themselves well. This study aimed to establish the PROMIS thresholds for the PASS in a primary cohort of TAR patients. Methods: This single-institution study included 127 primary TAR patients with preoperative and 2-year postoperative PROMIS scores. At 2 years postoperatively, patients answered 2 PASS anchor questions (Satisfaction, Delighted-Terrible scale) with Likert-scale responses. PASS thresholds with 95% confidence intervals (CIs) were calculated from PROMIS scores using an anchor-based method. Using a bootstrapping technique with 1,000 iterations, the Youden index was calculated to determine the best specificity and sensitivity coordinates to maximize their combination. Finally, preoperative variables associated with the likelihood of achieving the PASS were assessed. Results: There was a strong association between PASS thresholds and PROMIS domains, especially Pain Interference (PASS threshold of <56.0, area under the receiver operating characteristic curve [AUC] = 0.940), Pain Intensity (44.7, AUC = 0.883). The likelihood of achieving the PASS was not affected by age, race, gender, American Society of Anesthesiologists (ASA) class, body mass index, or severity of ankle deformity. Patients with worse preoperative Physical Function and Global Mental Health scores were less likely to meet the PASS threshold for Physical Function postoperatively (p = 0.028 and 0.041). Conclusions: The ability to reach the PASS after TAR was most strongly associated with postoperative PROMIS pain scores. However, PASS thresholds were generally poorer than population means. This demonstrates that patients do not need to reach normal pain or physical function levels to have an acceptable symptom state after TAR. Level of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
- 29 May 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (15) , 1404-1410
Defining the Patient Acceptable Symptom State (PASS) for PROMIS After Total Ankle Replacement
Background: Although patient-reported outcomes (PROs), such as the Patient-Reported Outcomes Measurement Information System (PROMIS), are a key element of evaluating success after total ankle replacement (TAR), many do not explicitly state a key factor of postoperative success: is the patient satisfied with their outcome after TAR? The patient acceptable symptom state (PASS) represents the symptom threshold beyond which patients consider themselves well. This study aimed to establish the PROMIS thresholds for the PASS in a primary cohort of TAR patients. Methods: This single-institution study included 127 primary TAR patients with preoperative and 2-year postoperative PROMIS scores. At 2 years postoperatively, patients answered 2 PASS anchor questions (Satisfaction, Delighted-Terrible scale) with Likert-scale responses. PASS thresholds with 95% confidence intervals (CIs) were calculated from PROMIS scores using an anchor-based method. Using a bootstrapping technique with 1,000 iterations, the Youden index was calculated to determine the best specificity and sensitivity coordinates to maximize their combination. Finally, preoperative variables associated with the likelihood of achieving the PASS were assessed. Results: There was a strong association between PASS thresholds and PROMIS domains, especially Pain Interference (PASS threshold of <56.0, area under the receiver operating characteristic curve [AUC] = 0.940), Pain Intensity (44.7, AUC = 0.883). The likelihood of achieving the PASS was not affected by age, race, gender, American Society of Anesthesiologists (ASA) class, body mass index, or severity of ankle deformity. Patients with worse preoperative Physical Function and Global Mental Health scores were less likely to meet the PASS threshold for Physical Function postoperatively (p = 0.028 and 0.041). Conclusions: The ability to reach the PASS after TAR was most strongly associated with postoperative PROMIS pain scores. However, PASS thresholds were generally poorer than population means. This demonstrates that patients do not need to reach normal pain or physical function levels to have an acceptable symptom state after TAR. Level of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
- 5 March 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (9) , 767-775
Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement
Background: Total ankle replacements (TARs) have rapidly advanced in terms of volume, technique, design, and indications. However, TARs are still at risk for early mechanical failure and revision. Prior studies have investigated potential risk factors for failure, but have been limited to smaller series or older implants. This study sought to identify risk factors for early mechanical failure in modern TAR. Methods: This is a retrospective study of a single-institution registry. Five surgeons contributed cases involving patients who underwent a primary TAR with any implant. Implants were grouped on the basis of the type of fixation. The primary outcome was early mechanical failure (revision with component removal for a non-infectious etiology, that is, subsidence, aseptic loosening, and/or malalignment). Logistic regression determined the effects of age, weight, hindfoot arthrodesis, implant type, and radiographic deformity on failure. Results: The 731 included patients had a mean follow-up of 2.7 years. Ten percent (71 patients) had hindfoot arthrodesis. There were 33 mechanical failures (4.5%) at a mean of 1.7 years after the index surgical procedure. Our model demonstrated that hindfoot arthrodesis was associated with 2.7 times greater odds of failure (p = 0.045), every 10 kg of body weight increased the odds of tibial-sided failure by 1.29 times (p = 0.039), and implants with more extensive tibial fixation (stems or keels) lowered the odds of tibial failure by 95% (p = 0.031). Conclusions: In patients with uncontrollable risk factors (hindfoot arthrodesis) or risk factors that may or may not be modifiable by the patient (weight), implants with more robust tibial fixation may be able to reduce the risk of early mechanical failure. Further research is warranted to support efforts to decrease early failure in TAR. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 5 March 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (9) , 767-775
Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement
Background: Total ankle replacements (TARs) have rapidly advanced in terms of volume, technique, design, and indications. However, TARs are still at risk for early mechanical failure and revision. Prior studies have investigated potential risk factors for failure, but have been limited to smaller series or older implants. This study sought to identify risk factors for early mechanical failure in modern TAR. Methods: This is a retrospective study of a single-institution registry. Five surgeons contributed cases involving patients who underwent a primary TAR with any implant. Implants were grouped on the basis of the type of fixation. The primary outcome was early mechanical failure (revision with component removal for a non-infectious etiology, that is, subsidence, aseptic loosening, and/or malalignment). Logistic regression determined the effects of age, weight, hindfoot arthrodesis, implant type, and radiographic deformity on failure. Results: The 731 included patients had a mean follow-up of 2.7 years. Ten percent (71 patients) had hindfoot arthrodesis. There were 33 mechanical failures (4.5%) at a mean of 1.7 years after the index surgical procedure. Our model demonstrated that hindfoot arthrodesis was associated with 2.7 times greater odds of failure (p = 0.045), every 10 kg of body weight increased the odds of tibial-sided failure by 1.29 times (p = 0.039), and implants with more extensive tibial fixation (stems or keels) lowered the odds of tibial failure by 95% (p = 0.031). Conclusions: In patients with uncontrollable risk factors (hindfoot arthrodesis) or risk factors that may or may not be modifiable by the patient (weight), implants with more robust tibial fixation may be able to reduce the risk of early mechanical failure. Further research is warranted to support efforts to decrease early failure in TAR. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.